SBS On the Money: CEO SERIES: ResMed reports as the ASX plunges
Medical device maker Resmed reports its earnings and signals potential partnerships with big tech. Rhayna Bosch talks to ResMed CEO Mick Farrell. Meanwhile – global share markets come crashing down – and Mahjabeen Zaman, the head of FX Researxch at ANZ Babnk says the ASX200 is clocking its WORST single trading day in 16 months.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.